Cell

LUMI-lab: An AI-driven platform for finding ionizable lipids that improve mRNA delivery

Updated

Abstract

Essence

An AI-robotics platform discovered new ionizable lipids that improved mRNA delivery, including a lead candidate that edited lung epithelial cells in mice.

Evidence

This autonomous discovery platform study used a transformer-based foundation model with active learning to synthesize and screen more than 1,700 lipid nanoparticles, identifying brominated tails as beneficial and a lead lipid, LUMI-6, that achieved 20.3% gene editing in mouse lung epithelial cells after intratracheal dosing.

Caveat

The main results are platform optimization and preclinical mouse and cell-system performance, so they do not show clinical efficacy or generalize beyond the tested delivery setting.

Simplified

Full Text

Full text is available at the source.

Funding

Competing interests

4 authors filed a patent for LUMI-lab, including its model and ionizable lipids; 1 advises Shift Bioscience, Deep Genomics, and Vevo Therapeutics and consults for Arsenal Bioscience.
PubMed

What Lands in Your Inbox Each Week:

  • 📚7 fresh studies
  • 📝plain-language summaries
  • direct links to original studies
  • 🏅top journal indicators
  • 📅weekly delivery
  • 🧘‍♂️always free